Analysts widely anticipate Beijing will announce an official deficit ratio of 4% of GDP, up from the long-maintained threshold of around 3% – with notable exceptions in 2020 and 2023.

BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced that it has entered into an exclusive License ...

Sustainalytics’ controversies research identifies companies involved in incidents and events that may negatively affect stakeholders, the environment or the company’s operations. Controversies are ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

We are excited for our guests to enjoy a best-in-class experience with Passport's payment solutions and the improved operational efficiencies ...

The best cloud storage services provide online storage for all your important files and data in the cloud. They should offer a good amount of storage and support a range of media types ...

CSPC Pharmaceutical increased 2.04 percent, Galaxy Entertainment slumped 1.17 percent, Haier Smart Home dropped 0.79 percent, Hang Lung Properties perked 0.16 percent, Henderson Land stumbled 2.61 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Here’s how it works. The best free cloud storage allows you to securely save a copy of your most important files in the cloud for safekeeping. Whether they be documents, images or even videos ...

CSPC Megalith Biopharmaceutical has entered into a license agreement with Radiance Biopharma (9993: HK) for the development and commercialization of SYS6005, a recombinant anti-human receptor tyrosine ...

BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., (“Radiance” or the “Company”), a biotechnology company, today announced that it has entered into an exclusive License ...

Radiance Biopharma is heating up the ROR1 race. The U.S. biotech is paying (PDF) China’s CSPC Megalith Biopharmaceutical $15 million upfront for rights to an antibody-drug conjugate (ADC ...